Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies

scientific article published on 06 January 2012

Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1093/ANNONC/MDR603
P698PubMed publication ID22228452
P5875ResearchGate publication ID221732320

P50authorAlicja WolkQ29998745
P2093author name stringN Orsini
A Discacciati
P2860cites workGlobal cancer statisticsQ22241238
Body-Mass Index and Mortality among 1.46 Million White AdultsQ22250878
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysisQ24625223
Quantifying heterogeneity in a meta-analysisQ27860672
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesQ29614869
Obesity and prostate cancer: making sense out of apparently conflicting dataQ31111552
Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analysesQ33437753
Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysisQ33975870
Risk factors for prostate cancer incidence and progression in the health professionals follow-up studyQ34621511
Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective studyQ35262921
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic CarcinomaQ36227180
Body size and composition and prostate cancer risk: systematic review and meta-regression analysisQ36577688
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC studyQ36613659
A prospective Swedish study on body size, body composition, diabetes, and prostate cancer riskQ37225717
Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortalityQ39781055
Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinicQ39833969
Body size and risk of prostate cancer in the European prospective investigation into cancer and nutritionQ40029406
High-grade prostate cancer is associated with low serum testosterone levelsQ43576700
Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohortQ43977874
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomyQ44398102
Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.Q46491237
Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohortQ46906130
Circulating steroid hormones and the risk of prostate cancerQ46910105
Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.Q47218906
Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition CohortQ47309159
Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.Q54229593
Anthropometrics and Prostate Cancer RiskQ58394394
Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention TrialQ58394513
P433issue7
P921main subjectprostate cancerQ181257
meta-analysisQ815382
P304page(s)1665-1671
P577publication date2012-01-06
P1433published inAnnals of OncologyQ326122
P1476titleBody mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies
P478volume23